0001209191-24-002949.txt : 20240206
0001209191-24-002949.hdr.sgml : 20240206
20240206202051
ACCESSION NUMBER: 0001209191-24-002949
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240205
FILED AS OF DATE: 20240206
DATE AS OF CHANGE: 20240206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shukla Sanjay
CENTRAL INDEX KEY: 0001671026
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 24601823
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 10240 SORRENTO VALLEY ROAD, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8587318389
MAIL ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-05
0
0001339970
aTYR PHARMA INC
LIFE
0001671026
Shukla Sanjay
10240 SORRENTO VALLEY ROAD
SUITE 300
SAN DIEGO
CA
92121
1
1
0
0
President and CEO
0
Common stock
2024-02-05
4
M
0
10375
A
116548
D
Restricted Stock Unit
2024-02-05
4
M
0
10375
0.00
D
Common Stock
10375
20750
D
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.
Restricted stock units convert into common stock on a one-for-one basis.
The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
/s/ Nancy E. Denyes, attorney-in-fact
2024-02-06